DK149778C - Analogifremgangsmaade til fremstilling af des-pheb1-humaninsulin eller derivater deraf - Google Patents

Analogifremgangsmaade til fremstilling af des-pheb1-humaninsulin eller derivater deraf

Info

Publication number: DK149778C
Authority: DK; Denmark
Prior art keywords: des; insulin; human insulin; denotes; ala
Prior art date: 1980-09-03

Application number

DK388081A

Other languages

English (en)

Other versions

DK388081A (da

DK149778B (da

Inventor

Rolf Geiger

Original Assignee

Hoechst Ag

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1980-09-03

Filing date

1981-09-02

Publication date

1987-04-06

1981-09-02 Application filed by Hoechst Ag filed Critical Hoechst Ag

1982-03-04 Publication of DK388081A publication Critical patent/DK388081A/da

1986-09-29 Publication of DK149778B publication Critical patent/DK149778B/da

1987-04-06 Application granted granted Critical

1987-04-06 Publication of DK149778C publication Critical patent/DK149778C/da

Links

101000976075 Homo sapiens Insulin Proteins 0.000 title abstract 2
PBGKTOXHQIOBKM-FHFVDXKLSA-N insulin (human) Chemical compound C([C@@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@H]1CSSC[C@H]2C(=O)N[C@H](C(=O)N[C@@H](CO)C(=O)N[C@H](C(=O)N[C@H](C(N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC=3C=CC(O)=CC=3)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC=3C=CC(O)=CC=3)C(=O)N[C@@H](CSSC[C@H](NC(=O)[C@H](C(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC=3C=CC(O)=CC=3)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](C(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC=3NC=NC=3)NC(=O)[C@H](CO)NC(=O)CNC1=O)C(=O)NCC(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)NCC(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(O)=O)C(=O)N[C@@H](CC(N)=O)C(O)=O)=O)CSSC[C@@H](C(N2)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](C(C)C)NC(=O)[C@@H](NC(=O)CN)[C@@H](C)CC)[C@@H](C)CC)[C@@H](C)O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](NC(=O)[C@@H](N)CC=1C=CC=CC=1)C(C)C)C1=CN=CN1 PBGKTOXHQIOBKM-FHFVDXKLSA-N 0.000 title abstract 2
238000000034 method Methods 0.000 title abstract 2
NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 abstract 5
102000004877 Insulin Human genes 0.000 abstract 2
108090001061 Insulin Proteins 0.000 abstract 2
150000001875 compounds Chemical class 0.000 abstract 2
229940125396 insulin Drugs 0.000 abstract 2
102000000496 Carboxypeptidases A Human genes 0.000 abstract 1
108010080937 Carboxypeptidases A Proteins 0.000 abstract 1
239000002253 acid Substances 0.000 abstract 1
230000015556 catabolic process Effects 0.000 abstract 1
238000006731 degradation reaction Methods 0.000 abstract 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/575—Hormones
- C07K14/62—Insulins
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides

Landscapes

Health & Medical Sciences (AREA)
Diabetes (AREA)
Chemical & Material Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Organic Chemistry (AREA)
General Health & Medical Sciences (AREA)
Endocrinology (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Veterinary Medicine (AREA)
General Chemical & Material Sciences (AREA)
Obesity (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Hematology (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Animal Behavior & Ethology (AREA)
Emergency Medicine (AREA)
Public Health (AREA)
Chemical Kinetics & Catalysis (AREA)
Toxicology (AREA)
Zoology (AREA)
Gastroenterology & Hepatology (AREA)
Biochemistry (AREA)
Biophysics (AREA)
Genetics & Genomics (AREA)
Molecular Biology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Peptides Or Proteins (AREA)
Medicines Containing Material From Animals Or Micro-Organisms (AREA)

DK388081A 1980-09-03 1981-09-02 Analogifremgangsmaade til fremstilling af des-pheb1-humaninsulin eller derivater deraf DK149778C (da)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
DE19803033127 DE3033127A1 (de)	1980-09-03	1980-09-03	Neue analoga des insulins
DE3033127		1980-09-03

Publications (3)

Publication Number	Publication Date
DK388081A DK388081A (da)	1982-03-04
DK149778B DK149778B (da)	1986-09-29
DK149778C true DK149778C (da)	1987-04-06

Family

ID=6111025

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
DK388081A DK149778C (da)	1980-09-03	1981-09-02	Analogifremgangsmaade til fremstilling af des-pheb1-humaninsulin eller derivater deraf

Country Status (9)

Country	Link
EP (1)	EP0046979B1 (da)
JP (1)	JPS5777655A (da)
AT (1)	ATE4591T1 (da)
AU (1)	AU545399B2 (da)
CA (1)	CA1173388A (da)
DE (2)	DE3033127A1 (da)
DK (1)	DK149778C (da)
ES (1)	ES505039A0 (da)
ZA (1)	ZA816085B (da)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE3327928A1 (de) *	1983-08-03	1985-02-21	Hoechst Ag, 6230 Frankfurt	Verfahren zur herstellung von insulin-derivaten
DE3333640A1 (de) *	1983-09-17	1985-04-25	Hoechst Ag, 6230 Frankfurt	Verfahren zur herstellung von insulin-derivaten, deren b-kette c-terminal verlaengert ist, neue basisch modifizierte insulin-derivate diese enthaltende mittel und ihre verwendung
DK347086D0 (da) *	1986-07-21	1986-07-21	Novo Industri As	Novel peptides
DE3837825A1 (de) *	1988-11-08	1990-05-10	Hoechst Ag	Neue insulinderivate, ihre verwendung und eine sie enthaltende pharmazeutische zubereitung
CN1125081C (zh)	1999-09-08	2003-10-22	中国科学院上海生物化学研究所	重组天然和新型人胰岛素及其制备方法
DE10114178A1 (de)	2001-03-23	2002-10-10	Aventis Pharma Gmbh	Zinkfreie und zinkarme Insulinzubereitungen mit verbesserter Stabilität
DE10227232A1 (de)	2002-06-18	2004-01-15	Aventis Pharma Deutschland Gmbh	Saure Insulinzubereitungen mit verbesserter Stabilität
RS59913B1 (sr)	2008-10-17	2020-03-31	Sanofi Aventis Deutschland	Kombinacija insulina i glp-1-agonista
SG10201403840VA (en)	2009-07-06	2014-10-30	Sanofi Aventis Deutschland	Aqueous insulin preparations containing methionine
PL2498801T3 (pl)	2009-11-13	2018-08-31	Sanofi Aventis Deutschland	Kompozycja farmaceutyczna zawierająca desPro<sup>36</sup>eksendyno-4(1-39)-Lys6-NH2 i metioninę
SI2498802T1 (sl)	2009-11-13	2015-05-29	Sanofi-Aventis Deutschland Gmbh	Farmacevtski sestavek, ki vsebuje agonist GLP-1, inzulin in metionin
BR112013004756B1 (pt)	2010-08-30	2020-04-28	Sanofi Aventis Deutschland	uso de ave0010 para a fabricação de um medicamento para o tratamento da diabetes melito tipo 2
US9821032B2 (en)	2011-05-13	2017-11-21	Sanofi-Aventis Deutschland Gmbh	Pharmaceutical combination for improving glycemic control as add-on therapy to basal insulin
CA2846413C (en)	2011-08-29	2021-11-02	Sanofi-Aventis Deutschland Gmbh	Pharmaceutical combination for use in glycemic control in diabetes type 2 patients
TWI559929B (en)	2011-09-01	2016-12-01	Sanofi Aventis Deutschland	Pharmaceutical composition for use in the treatment of a neurodegenerative disease
TWI758239B (zh)	2014-12-12	2022-03-21	德商賽諾菲阿凡提斯德意志有限公司	甘精胰島素/利司那肽固定比率配製劑
TWI748945B (zh)	2015-03-13	2021-12-11	德商賽諾菲阿凡提斯德意志有限公司	第２型糖尿病病患治療
TW201705975A (zh)	2015-03-18	2017-02-16	賽諾菲阿凡提斯德意志有限公司	第２型糖尿病病患之治療
CN113773398B (zh) *	2020-06-10	2023-05-23	宁波鲲鹏生物科技有限公司	一种德谷胰岛素衍生物及其应用

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US3364116A (en) *	1964-11-02	1968-01-16	Squibb & Sons Inc	Method of use of desalanino insulin compositions
DE2256215C3 (de) *	1972-11-16	1981-01-08	Hoechst Ag, 6000 Frankfurt	Insulin-Zubereitung mit einem Gehalt an kristallinem Insulin und amorphem Desphenylalanin8' -insulin

1980
- 1980-09-03 DE DE19803033127 patent/DE3033127A1/de not_active Withdrawn
1981
- 1981-08-26 DE DE8181106625T patent/DE3160852D1/de not_active Expired
- 1981-08-26 EP EP81106625A patent/EP0046979B1/de not_active Expired
- 1981-08-26 AT AT81106625T patent/ATE4591T1/de not_active IP Right Cessation
- 1981-08-28 ES ES505039A patent/ES505039A0/es active Granted
- 1981-09-01 JP JP56136212A patent/JPS5777655A/ja active Pending
- 1981-09-02 AU AU74883/81A patent/AU545399B2/en not_active Ceased
- 1981-09-02 DK DK388081A patent/DK149778C/da active
- 1981-09-02 ZA ZA816085A patent/ZA816085B/xx unknown
- 1981-09-02 CA CA000385067A patent/CA1173388A/en not_active Expired

Also Published As

Publication number	Publication date
EP0046979A1 (de)	1982-03-10
EP0046979B1 (de)	1983-09-07
ES8206448A1 (es)	1982-08-16
ZA816085B (en)	1982-08-25
AU545399B2 (en)	1985-07-11
DK388081A (da)	1982-03-04
DK149778B (da)	1986-09-29
ATE4591T1 (de)	1983-09-15
AU7488381A (en)	1982-03-11
DE3160852D1 (en)	1983-10-13
ES505039A0 (es)	1982-08-16
CA1173388A (en)	1984-08-28
DE3033127A1 (de)	1982-04-08
JPS5777655A (en)	1982-05-15

Similar Documents

Publication	Publication Date	Title
DK149778C (da)	1987-04-06	Analogifremgangsmaade til fremstilling af des-pheb1-humaninsulin eller derivater deraf
DK393288D0 (da)	1988-07-14	Praeparat til saarheling og knogleregenerering
IT7827181A0 (it)	1978-08-31	Procedimento di preparazione di polieter-ester-ammidi a sequenze, utilizzabili, fra l'altro, come prodotti da stampare, da estrudere o da filare.
IT7949753A0 (it)	1979-07-13	Composizione per proteggere la pelle dai raggi del sole e procedimento per la sua preparazione
PT69058A (de)	1979-02-01	1,2,4-oxadiazolderivate verfahren zur herstellung dieser verbindungen sowie diese enthaltende selektive herbizide mittel
PH15773A (en)	1983-03-24	Method and composition for regulating plant growth using cycloalkane-carboxylic acid compounds
DE2860810D1 (en)	1981-10-08	1-ethyl-7-chloro-6-fluoro-4-quinolone-3-carboxylic acid, its preparation and application as plant bactericide
LU79376A1 (de)	1978-07-13	1,2,3-thiadiazol-3-in-5-yliden-harnstoffe,verfahren zur herstellung dieser verbindungen sowie diese enthaltende mittel mit wachstumsregulatorischer wirkung
DK87190A (da)	1990-04-06	Fremgangsmaade til at regulere plantevaekst under anvendelse af svovlholdige organiske syrer
PT69999A (de)	1979-08-01	1,2,3-triazolcarbonsaureamide verfahren zur herstellung dieser verbindungen sowie diese enthaltende biozide mittel
Callaghan et al.	1981	The yield, development and chemical composition of some fast-growing indigenous and naturalised British plant species in relation to management as energy crops.
JPS54163812A (en)	1979-12-26	Substituted benzorylthioalkanoic acid as plant growth regulating agent
IL56412A0 (en)	1979-03-12	Novel halogen-substituted pyrimidin -2-ylthiono-thiol-phosphonic acid esters, their preparation and their use as insecticides and acaricides
DE3262384D1 (en)	1985-03-28	Fungicidal composition comprising alpha-substituted ethylphosphinic acids or their salts, and method of preventing or curing plant disease using them
ZA792149B (en)	1980-06-25	N,n-dimethyl-o-pyrazolyl-carbamic acid esters,processes for their preparation and their use as insecticides
IL57778A (en)	1982-12-31	2-cyclopropyl-pyrimidin-4-ylthionophosphonic acid esters,their preparation and their use as insecticides and acaricides
DE2960306D1 (en)	1981-08-06	Alpha-isopropyl-phenylacetic acid esters, their preparation and use as pesticides
JPS57116042A (en)	1982-07-19	Racemic compound or optically active compound, plant growth regulant composition, manufacture and agricultural use
IL60064A0 (en)	1980-07-31	Fluorine-substituted oxyalkenyl-cyclo-propane-carboxylic acid esters,their preparation and their use as insecticides and acaricides
IL58331A0 (en)	1979-12-30	Substituted bromostyrl-cyclopropanecarboxylic acid phenoxybenzyl esters, their preparation and their use as insecticides and acaricides
PT76582A (de)	1983-05-01	1,2,4-triazol-1-yl-propionitrile verfahren zur herstellung dieser verbindungen sowie diese enthaltende biozide mittel
DE2860733D1 (en)	1981-08-27	(1,2,3,4,5,6h)-triazine-2,4-diones, method for their preparation and their use as insecticides
MN173A6 (en)	1981-03-15	Triethanolamine salt of 2,4-chlorophenoxycetic acid as biological stimulant
DK391482A (da)	1983-03-03	Fremgangsmaade til fremstilling af ren 6,6-diiodpenicillansyre ved diazotering af 6beta-aminopenicillansyre i naervaer af iod
PT75591A (de)	1982-10-01	1,2,3-thiadiazol-5-yl-harnstoff-derivate verfahren zur herstellung dieser verbindungen sowie diese enthaltende mittel mit wughsregulatorischer und entblaetternder wirkung